Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective

Por Eckstein, Niels, Röper, Lea, Haas, Bodo, Potthast, Henrike, Hermes, Ulrike, Unkrig, Christoph, Naumann-Winter, Frauke, Enzmann, Harald
Publicado em 2014

The European Medicines Agency Review of Bosutinib for the Treatment of Adult Patients With Chronic Myelogenous Leukemia: Summary of the Scientific Assessment of the Committee for M...

Por Hanaizi, Zahra, Unkrig, Christoph, Enzmann, Harald, Camarero, Jorge, Sancho-Lopez, Arantxa, Salmonson, Tomas, Gisselbrecht, Christian, Laane, Edward, Pignatti, Francesco
Publicado em 2014